U.S. Preventive Medicine and deCODE Genetics Sign Letter of Intent to Expand Personalized Medicin... (providers toshare knowledge experiences ...)

U.S. Preventive Medicine and deCODE Genetics Sign Letter of Intent to Expand Personalized Medicine Platform

Date:4/3/2008

providers to share knowledge, experiences, new technologies and services, while providing the best possible preventive health programs."

According to U.S. Preventive Medicine National Policy Advisor and former Secretary of the U.S. Department of Health & Human Services, Gov. Tommy Thompson, "The addition of deCODE's DNA profiling services as a option for the individuals the company assists is a natural evolution in the direction of the demand for personalized medicine. This is a very important step for U.S. Preventive Medicine in their role as the leader of this crucial area of health care."

About U.S. Preventive Medicine:

U.S. Preventive Medicine(R), a privately owned company, is building the first personalized medicine business in the United States and internationally focused on prevention. They offer employers, government agencies and consumers proprietary products that include The Prevention Plan(TM), a groundbreaking personalized wellness program delivered online to individuals; The Prevention Plan CM(TM), field-based chronic disease management programs customized for employers and government agencies to reduce healthcare costs; and The Centers for Preventive Medicine(R), which offer high-tech diagnostic screenings delivered to consumers in partnership with hospitals, health systems and other providers. For more information, please visit http://www.USPreventiveMedicine.com.

About deCODE

deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs and diagnostics for common diseases. deCODE is a global leader in gene discovery -- our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are providing us with drug targets rooted in the basic biology of disease. deCODE is also leveraging its expertise in hu
'/>"/>

0

GOOD

Page: 1 2 3
Related biology technology :

1. U.S. Preventive Medicine National Policy Advisor Gov. Tommy Thompson to Propose Prevention is the Solution at UBS Global Health Services Conference
2. Protherics UK Ltd. Chooses TrackWise for Corrective Action and Preventive Action (CAPA) Management
3. Vicus Therapeutics Announces Participation at 15th International Molecular Medicine Tri-Conference
4. WaferGen to Present at the Cambridge Health Institutes Fifth Annual Molecular Diagnostics Partnerships in Personalized Medicine Conference
5. Spectral announces new findings on the effectiveness of EAA(TM)/Toraymyxin(TM) at the 28th International Symposium on Intensive Care and Emergency Medicine
6. NeoStems Denis Rodgerson, Ph.D. to Lecture on Stem Cells and Regenerative Medicine at University of Nevada Las Vegas Campus
7. Partnership With SearchMedica.com to Enhance Web Searches on ModernMedicine.com
8. Center for Molecular Medicine Partners with AviaraDx to Offer New Cancer Tests to Aid Physicians in Personalizing Treatment
9. Center for Molecular Medicine Among First to Offer New FDA-Approved Test to Aid in Treatment of Prostate Cancer
10. Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management
11. Data from Two Pivotal Trials of AMRIX, a New Once-Daily Extended-Release Muscle Relaxant, Presented at the American Academy of Pain Medicine Meeting

Post Your Comments:

U.S. Preventive Medicine and deCODE Genetics Sign Letter of Intent to Expand Personalized Medicin...(providers toshare knowledge experiences ...)